Study estimates COVID-19 hospitalization and mortality rates in the US during the pre-vaccination period, revealing significant age and racial disparities in outcomes.
Pfizer plans $3.5B in cost cuts as sales of Covid products continue to slide
Pfizer confirmed late Friday that it will launch a company-wide cost-cutting program this year and next as sales of the drugmaker’s Covid vaccine and antiviral